Viral hepatitis and pregnancy

Autor: Miriam T. Levy, Norah A. Terrault, Ka Wang Cheung, Gonzague Jourdain
Přispěvatelé: Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])
Rok vydání: 2020
Předmět:
MESH: Antiviral Agents
0301 basic medicine
MESH: Premature Birth
MESH: Hepatitis
Chronic

viruses
Hepatitis C virus
medicine.disease_cause
03 medical and health sciences
Liver disease
MESH: Perinatal Mortality
MESH: Pregnancy
0302 clinical medicine
medicine
MESH: Infant Mortality
MESH: Pregnancy Complications
Infectious

MESH: Hepatitis
Viral
Human

MESH: Diabetes
Gestational

MESH: Hepatitis C
Hepatitis
Hepatitis B virus
MESH: Hepatitis D
MESH: Humans
MESH: Hepatitis A
MESH: Hepatitis B
Hepatology
MESH: Viral Hepatitis Vaccines
business.industry
MESH: Infant
Newborn

MESH: Hepatitis E
Gastroenterology
Hepatitis A
MESH: Pregnancy Outcome
medicine.disease
MESH: Infant
3. Good health
MESH: Infectious Disease Transmission
Vertical

030104 developmental biology
Immunology
MESH: Acute Disease
030211 gastroenterology & hepatology
MESH: Maternal Mortality
Hepatitis D virus
MESH: Liver Cirrhosis
MESH: Viral Load
Viral hepatitis
business
MESH: Female
Viral load
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Zdroj: Nature reviews. Gastroenterology & hepatology
Nature reviews. Gastroenterology & hepatology, Nature Publishing Group, 2009-, 2021, 18 (2), pp.117-130. ⟨10.1038/s41575-020-00361-w⟩
ISSN: 1759-5053
1759-5045
DOI: 10.1038/s41575-020-00361-w
Popis: The management of viral hepatitis in the setting of pregnancy requires special consideration. There are five liver-specific viruses (hepatitis A, B, C, D, E), each with unique epidemiology, tendency to chronicity, risk of liver complications and response to antiviral therapies. In the setting of pregnancy, the liver health of the mother, the influence of pregnancy on the clinical course of the viral infection and the effect of the virus or liver disease on the developing infant must be considered. Although all hepatitis viruses can harm the mother and the child, the greatest risk to maternal health and subsequently the fetus is seen with acute hepatitis A virus or hepatitis E virus infection during pregnancy. By contrast, the primary risks for hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus are related to the severity of the underlying liver disease in the mother and the risk of mother-to-child transmission (MTCT) for HBV and HCV. The prevention of MTCT is key to reducing the global burden of chronic viral hepatitis, and prevention strategies must take into consideration local health-care and socioeconomic challenges. This Review presents the epidemiology of acute and chronic viral hepatitis infection in pregnancy, the effect of pregnancy on the course of viral infection and, conversely, the influence of the viral infection on maternal and infant outcomes, including MTCT. The management of viral hepatitis in the setting of pregnancy requires special consideration. This Review examines each hepatitis virus individually to address the effect of pregnancy on the natural history of infection and how the viral infections influence maternal and infant outcomes, including mother-to-child transmission.
Databáze: OpenAIRE